Cigarette smoking is the leading preventable cause of death and disability. Although most US smokers want to quit, more than 95% of cessation attempts end in relapse within 6 months. To improve cessation outcomes, research has turned to targetable mechanisms, such as anxiety sensitivity (AS), which maintain smoking behaviour, impede cessation success, and can be effectively targeted in the context of psychosocial interventions. Although integrated treatment programmes that address AS reduction in the context of smoking cessation have demonstrated promising results, presently, no mobile, technology-based integrated treatment exists to expressly address smoking and AS. The current study evaluated the initial feasibility and acceptability of a mobile smoking cessation intervention, Mobile Anxiety Sensitivity Program for smoking (MASP).

中文翻译：

---

评估基于移动的戒烟健康技术的可行性和可接受性：移动焦虑敏感性计划

吸烟是导致死亡和残疾的主要可预防原因。尽管大多数美国吸烟者想戒烟，但超过 95% 的戒烟尝试在 6 个月内以复发告终。为了改善戒烟结果，研究转向了可靶向的机制，例如焦虑敏感性 (AS)，它可以维持吸烟行为、阻碍戒烟成功，并且可以在社会心理干预的背景下有效靶向。尽管在戒烟的情况下解决 AS 减少的综合治疗计划已经显示出有希望的结果，但目前，还没有移动的、基于技术的综合治疗来明确解决吸烟和 AS。目前的研究评估了移动戒烟干预的初步可行性和可接受性，即移动吸烟焦虑敏感性计划 (MASP)。